Two large analyses published this week quantified a sharp rise in chronic kidney disease (CKD) burden: prevalence has more than doubled since 1990, with nearly 788 million adults showing diminished kidney function in 2023, and CKD has climbed into the top ten global causes of death. The findings come from The Lancet and related global mortality reports analyzing decades of population data. Authors attribute the rise to demographic shifts (population growth and aging) and increasing cardiometabolic disease. The reports call for expanded prevention, early detection, and equitable access to kidney care worldwide; they also informed concurrent clinical research on SGLT2 inhibitors and kidney outcomes presented at major nephrology meetings.